DBTECH

Dear Reader, As per your request, you have been removed from our mailing list for Politics and Nation Get all the updates from the world of business straight to your inbox Getting bigger and stronger. 4 million+ subscribers MANAGE ALL NEWSLETTERS » Daily Newsletter

VIEW IN BROWSER | SUBSCRIBE WED, OCT 23, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Happy Wednesday! Yet another study shows that blockbuster GLP-1 drugs may offer health benefits beyond diabetes and weight loss.  This time, more research is showing that they may significantly curb addictive behaviors.  Drugs such as Novo Nordisk's highly popular diabetes injection Ozempic can cut drug and alcohol abuse by around half, according to a new study published last week in the scientific journal Addiction. That suggests Ozempic and similar medications could potentially become a new treatment for opioid and alcohol use disorder.  "This study not only contributes to the evolving landscape of substance use therapy but also opens avenues for more comprehensive and effective treatment strategies for those affected by" the two disorders, the study authors wrote .  Here's why that'